whole-cell pertussis vaccine
GPTKB entity
Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:vaccine
|
| gptkbp:administeredBy |
intramuscular injection
|
| gptkbp:broadcastOn |
multiple doses
|
| gptkbp:contains |
inactivated Bordetella pertussis bacteria
|
| gptkbp:effect |
high
|
| gptkbp:foundIn |
low- and middle-income countries
|
| gptkbp:introducedIn |
1940s
|
| gptkbp:notRecommendedFor |
adults (in most countries)
|
| gptkbp:prevention |
pertussis
|
| gptkbp:recommendation |
infants
|
| gptkbp:replacedBy |
acellular pertussis vaccine (in many countries)
|
| gptkbp:sideEffect |
fever
irritability swelling local redness rare neurological reactions |
| gptkbp:storage |
refrigeration
|
| gptkbp:usedIn |
DTwP vaccine
Tdap vaccine (historically) |
| gptkbp:WHOStatus |
gptkb:World_Health_Organization_Model_List_of_Essential_Medicines
|
| gptkbp:bfsParent |
gptkb:Bordetella_pertussis
|
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
whole-cell pertussis vaccine
|